Tweet
J Crit Care Med (Targu Mures)
. 2021 Nov 13;8(1):41-48.
doi: 10.2478/jccm-2021-0032. eCollection 2022 Jan.
Hypercoagulopathy in Overweight and Obese COVID-19 Patients: a Single-Center Case Series
Azza Sarfraz 1 2 , Zouina Sarfraz 1 3 , Aman Siddiqui 1 4 , Ali Totonchian 4 , Syed Hashim Abbas Ali Bokhari 5 , Hafiza Hussain 3 , Muzna Sarfraz 1 , Gaurav Patel 1 , Muhammad Hassaan Amjad 6 , Sameer Saleem Tebha 1 , Ivan Cherrez-Ojeda 7 8 , Patrick Dreyer 1 , Harshad Amin 1 , Jack Michel 1
Affiliations
- PMID: 35274054
- PMCID: PMC8852292
- DOI: 10.2478/jccm-2021-0032
Abstract
A case series is presented of five overweight or obese patients with confirmed coronavirus disease 2019 (COVID-19) in South Miami, Florida, United States. A multitude of coagulation parameters was suggestive of a hypercoagulable state among the hospitalized COVID-19 patients. This article reports various manifestations of hypercoagulable states in overweight and obese patients, such as overt bleeding consistent with disseminated intravascular coagulation, venous thromboembolism, gastrointestinal bleeding as well as retroperitoneal hematoma. All of the required admission to the intensive care unit and subsequently patients died. The characteristics of COVID-19-associated coagulopathy are atypical and warrant a further understanding of the pathophysiology to improve clinical outcomes, specifically in overweight or obese patients.
Keywords: Coronavirus disease 2019; D-dimer; covid-19-associated coagulopathy; disseminated intravascular coagulation; heparin; obesity; venous thromboembolism.